Showing results (101-110 of 236) with videos related to
Sort By:
Pageof 24
Journal of Cancer Research and Clinical Oncology|May 28, 2018
The value of EBV DNA in early detection of post-transplant lymphoproliferative disorders among solid organ and hematopoietic stem cell transplant recipientsNeval E Wareham, Amanda Mocroft, Henrik Sengeløv, et al.BMC Nephrology|March 27, 2014
Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: the D:A:D studyDavid A Kamara, Lene Ryom, Michael Ross, et al.Liver International : Official Journal of the International Association for the Study of the Liver|April 16, 2015
Hepatitis C seroconversions in HIV infection across Europe: which regions and patient groups are affected?Christoph Boesecke, Daniel Grint, Vincent Soriano, et al.AIDS (London, England)|May 6, 2016
Associations between HIV-RNA-based indicators and virological and clinical outcomesKamilla G Laut, Leah C Shepherd, Court Pedersen, et al.Journal of the International AIDS Society|November 14, 2014
A clinically useful risk-score for chronic kidney disease in HIV infectionAmanda Mocroft, Jens Lundgren, Michael Ross, et al.Frontiers in Immunology|May 3, 2021
Independent Associations of Tumor Necrosis Factor-Alpha and Interleukin-1 Beta With Radiographic Emphysema in People Living With HIVRebekka F Thudium, Hedda Ringheim, Andreas Ronit, et al.Frontiers in Immunology|October 29, 2020
Impact of Age and HIV Status on Immune Activation, Senescence and ApoptosisMalene Hove-Skovsgaard, Yanan Zhao, Jeanette Linnea Tingstedt, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|June 12, 2008
Transmitted drug resistant HIV-1 and association with virologic and CD4 cell count response to combination antiretroviral therapy in the EuroSIDA StudyWendy P Bannister, Alessandro Cozzi-Lepri, Bonaventura Clotet, et al.Antiviral Therapy|March 27, 2009
Absence of a relation between efavirenz plasma concentrations and toxicity-driven efavirenz discontinuations in the EuroSIDA studyMatthijs van Luin, Wendy P Bannister, Amanda Mocroft, et al.AIDS (London, England)|June 3, 2009
Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapyAnouk M Kesselring, Ferdinand W Wit, Caroline A Sabin, et al.Pageof 24